Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19.
Ontology highlight
ABSTRACT: While establishing worldwide collective immunity with anti SARS-CoV-2 vaccines, COVID-19 remains a major health issue with dramatic ensuing economic consequences. In the transition, repurposing existing drugs remains the fastest cost-effective approach to alleviate the burden on health services, most particularly by reducing the incidence of the acute respiratory distress syndrome associated with severe COVID-19. We undertook a computational repurposing approach to identify candidate therapeutic drugs to control progression towards severe airways inflammation during COVID-19. Molecular profiling data were obtained from public sources regarding SARS-CoV-2 infected epithelial or endothelial cells, immune dysregulations associated with severe COVID-19 and lung inflammation induced by other re
SUBMITTER: Desvaux E
PROVIDER: S-EPMC8297899 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA